SuperworthFossil EPS FOSL
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jul 4, 2026
- −$1.27
- Latest quarter, Q2 FY26
- −$0.18
- Fiscal year 2025
- −$1.45
Fossil's earnings per share was −$1.27 over the twelve months to Jul 4, 2026.
In its latest quarter, Q2 FY26, it was −$0.18.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.45 | n/a |
| FY2024 | −$1.93 | n/a |
| FY2023 | −$3.01 | n/a |
| FY2022 | −$0.85 | −277% |
| FY2021 | $0.48 | n/a |
| FY2020 | −$1.90 | n/a |
| FY2019 | −$1.05 | n/a |
| FY2018 | −$0.09 | n/a |
| FY2017 | −$9.87 | −706% |
| FY2016 | $1.63 | −64% |
| FY2015 | $4.52 | −37% |
| FY2014 | $7.16 | +8% |
| FY2013 | $6.62 | +18% |
| FY2012 | $5.62 | +22% |
| FY2011 | $4.62 | +22% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.18 | n/a | −$1.27 | |
| Q1 FY26 | −$0.01 | n/a | −$1.13 | |
| Q4 FY25 | −$0.32 | n/a | −$1.45 | |
| Q3 FY25 | −$0.76 | n/a | −$1.27 | |
| Q2 FY25 | −$0.04 | n/a | −$1.11 | |
| Q1 FY25 | −$0.33 | n/a | −$1.80 | |
| Q4 FY24 | −$0.14 | n/a | −$1.93 | |
| Q3 FY24 | −$0.60 | n/a | −$2.33 | |
| Q2 FY24 | −$0.73 | n/a | −$2.89 | |
| Q1 FY24 | −$0.46 | n/a | −$2.67 | |
| Q4 FY23 | −$0.54 | n/a | −$3.01 | |
| Q3 FY23 | −$1.16 | −1155% | −$2.65 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Fossil's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| FOSLFossil | −$1.27 | |
| EMBCEmbecta | $1.47 | +3% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| MDXGMimedx | $0.04 | −81% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| MOVMovado | $1.80 | +137% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| BVSBioventus | $0.77 | |
| Peer median | $1.27 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Fossil
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.